Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP338308.RAD2Hv31I3802l-icgnnN3TQo0x8QOobRm8rpTs_t0ePk130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP338308.RAD2Hv31I3802l-icgnnN3TQo0x8QOobRm8rpTs_t0ePk130_assertion type Assertion NP338308.RAD2Hv31I3802l-icgnnN3TQo0x8QOobRm8rpTs_t0ePk130_head.
- NP338308.RAD2Hv31I3802l-icgnnN3TQo0x8QOobRm8rpTs_t0ePk130_assertion description "[The overall frequency of gene amplification among the gastric carcinomas rose to 19.4% when MYC, ERBB2, and INT2 were included in the analysis, with significant association with advanced tumor stage.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP338308.RAD2Hv31I3802l-icgnnN3TQo0x8QOobRm8rpTs_t0ePk130_provenance.
- NP338308.RAD2Hv31I3802l-icgnnN3TQo0x8QOobRm8rpTs_t0ePk130_assertion evidence source_evidence_literature NP338308.RAD2Hv31I3802l-icgnnN3TQo0x8QOobRm8rpTs_t0ePk130_provenance.
- NP338308.RAD2Hv31I3802l-icgnnN3TQo0x8QOobRm8rpTs_t0ePk130_assertion SIO_000772 8453595 NP338308.RAD2Hv31I3802l-icgnnN3TQo0x8QOobRm8rpTs_t0ePk130_provenance.
- NP338308.RAD2Hv31I3802l-icgnnN3TQo0x8QOobRm8rpTs_t0ePk130_assertion wasDerivedFrom befree-20140225 NP338308.RAD2Hv31I3802l-icgnnN3TQo0x8QOobRm8rpTs_t0ePk130_provenance.
- NP338308.RAD2Hv31I3802l-icgnnN3TQo0x8QOobRm8rpTs_t0ePk130_assertion wasGeneratedBy ECO_0000203 NP338308.RAD2Hv31I3802l-icgnnN3TQo0x8QOobRm8rpTs_t0ePk130_provenance.